Areva - Reference Document 2016

310 / 386

25 INFORMATION ON HOLDINGS
25.1. SIGNIFICANT EQUITY INTERESTS OF AREVA
Not applicable.
25.2. SHAREHOLDERS’ AGREEMENTS
25.2.1. SHAREHOLDERS’ AGREEMENTS CONCERNING AREVA SHARES
Except for agreements described hereunder, there is, to AREVA’s knowledge, no
agreement containing rights of first refusal concerning at least 0.5% of AREVA’s
share capital or voting rights.
SHAREHOLDERS’ AGREEMENT BETWEEN THE FRENCH STATE,
THE CEA AND KIA
The French State, the CEA and KIA entered into a 10-year shareholders’ agreement
effective December 28, 2010, whose key provisions are as follows:
p the French State has a preemptive right in the event that KIA sells all or part of
its equity interest, except for sales of shares made on the market;
p KIA has an absolute right to dispose of its shares in the event of a change in
control of AREVA, in the meaning of article L. 233-3 of the French Commercial
Code.
The French State has an option to purchase the shares in the event that KIA violates
its commitment regarding the preemptive right. The exercise price for the purchase
option shall be calculated based on the average weighted closing price of AREVA
shares during the 90 trading days preceding the date of exercise of the option.
Within the framework of the General Meeting of Shareholders of February 3, 2017,
in which the capital increase reserved for the French State with cancellation of the
shareholders’ preemptive subscription right was decided, KIA did not exercise its
anti-dilution right.
MEMORANDUM OF UNDERSTANDING BETWEEN TOTAL CHIMIE,
TOTAL NUCLÉAIRE AND AREVA
Under the terms of amemorandumof agreement dated June 27, 2001, Total Chimie
and Total Nucléaire agree to retain their AREVA securities until such time as AREVA
shares are admitted for trading on a regulated market. Although all AREVA shares
are now traded on a regulated market, neither Total Chimie nor Total Nucléaire has
yet chosen to dispose of their AREVA shares.
310 2016 AREVA REFERENCE DOCUMENT